Improved conditioning for hematopoietic chimerism induces islet tolerance to cure diabetes
JCI Insight · 08.06.2026 · 11 (11)
DOI: 10.1172/jci.insight.194491 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 09.04.2026. Verfasst von Stephan A Ramos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental Biology. Hauptthemen laut MEDLINE: Islets of Langerhans Transplantation, Transplantation Conditioning, Hematopoietic Stem Cell Transplantation, Diabetes Mellitus, Experimental. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute for Immunity, Transplantation and Infection – Stanford Autoimmunity & Allergy Supergroup, National Institutes of Health, Stanford Bio-X.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Mixed hematopoietic chimerism after hematopoietic cell transplantation (HCT) can modulate the immune system and induce tolerance to allogeneic tissues. However, bone marrow conditioning–related toxicities preclude wider adoption of HCT for transplant allotolerance. We sought agents that reduced conditioning intensity, while promoting durable mixed chimerism after HCT across complete MHC mismatch in diabetic mice, permitting islet allotransplantation and diabetes reversal. We systematically tested baricitinib (JAK1/2 inhibitor), venetoclax (Bcl-2 inhibitor), and CD47 antibody, agents in current clinical use, and quantified hematopoietic chimerism after HCT. Combined with CD117 antibody, transient T cell depletion, and just 10 centigray total body irradiation, these agents enabled durable mixed chimerism and matching alloislet tolerance to cure diabetes without evidence of graft-versus-host disease. Thus, we have developed a conditioning regimen to promote allogeneic mixed hematopoietic chimerism and transplanted islet allotolerance that minimizes conditioning radiation and cures diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Developmental Biology.
- Division of Blood and Marrow Transplantation, Department of Medicine.
- Stanford Diabetes Research Center, and.
- Northern California Breakthrough T1D Center of Excellence, Stanford School of Medicine, Stanford, California, USA.
Förderung
- Institute for Immunity, Transplantation and Infection – Stanford Autoimmunity & Allergy Supergroup
- National Institutes of Health
- Stanford Bio-X
- Juvenile Diabetes Research Foundation International
Zitieren
APA
Ramos, S. A., Bhagchandani, P., Burgos, D. M., Gu, X., Rodriguez, R., Nourin, N., Neukam, M., Pathak, S., Shizuru, J. A., & Kim, S. K. (2026). Improved conditioning for hematopoietic chimerism induces islet tolerance to cure diabetes. JCI Insight, 11(11). https://doi.org/10.1172/jci.insight.194491
Vancouver
Ramos SA, Bhagchandani P, Burgos DM, Gu X, Rodriguez R, Nourin N, et al. Improved conditioning for hematopoietic chimerism induces islet tolerance to cure diabetes. JCI Insight. 2026;11(11). doi:10.1172/jci.insight.194491
BibTeX
@article{Ramos2026,
author = {Ramos, Stephan A and Bhagchandani, Preksha and Burgos, Diego M and Gu, Xueying and Rodriguez, Richard and Nourin, Nadia and Neukam, Martin and Pathak, Shiva and Shizuru, Judith A and Kim, Seung K},
title = {Improved conditioning for hematopoietic chimerism induces islet tolerance to cure diabetes},
journal = {JCI Insight},
year = {2026},
volume = {11},
number = {11},
doi = {10.1172/jci.insight.194491}
}
EUVIMED